Cipher Pharma 2023 Investor Presentation: Specialty Pharma Strategy

Cipher Pharmaceuticals presents its lean operating model focused on acquiring and licensing specialty pharmaceutical products with cash generation and favorable risk-return profiles. The company demonstrates profitability today while outlining growth strategies through selective licensing in high-need therapeutic areas with infrastructure-light commercialization partnerships.